SCHEMBL2493671

SCHEMBL2493671

COc1ccccc1C1(CC(=O)N2CCN(c3ncccn3)CC2)C(=O)Nc2ccc(Cl)cc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.49
LMNA P02545 3/20 0.49
ADAM17 P78536 3/20 0.47
ADAMTS5 Q9UNA0 3/20 0.47
MMP13 P45452 2/20 0.47
ALDH1A1 P00352 5/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MMP2 P08253 2/20 0.45
POLB P06746 3/20 0.45
SMN1; SMN2 Q16637 1/20 0.44
MAPT P10636 3/20 0.43
NPC1 O15118 1/20 0.43
GAA P10253 1/20 0.43
TSHR P16473 1/20 0.43
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
MAPK1 P28482 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2496303 0.92 KDM4E (0.54) KDM4ELMNAADAM17ADAMTS5MMP13
SCHEMBL2499319 0.89 ADAM17 (0.50) LMNAADAM17ADAMTS5MMP13MMP2
SCHEMBL2499269 0.88 ADAM17 (0.44) KDM4ELMNAADAM17ADAMTS5MMP13
SCHEMBL2494093 0.88 ADAM17 (0.44) KDM4ELMNAADAM17ADAMTS5MMP13
SCHEMBL2492747 0.87 ADAMTS5 (0.50) ADAM17ADAMTS5MMP13MMP2NPC1
SCHEMBL2498584 0.87 ADAM17 (0.45) KDM4ELMNAADAM17ADAMTS5MMP13
SCHEMBL2492641 0.83 TP53 (0.44) LMNAADAM17ADAMTS5MMP13MMP2
SCHEMBL5674476 0.83 HTR7 (0.45) LMNAADAM17ADAMTS5MMP13ALDH1A1
SCHEMBL5675399 0.80 ADAMTS5 (0.41) LMNAADAM17ADAMTS5MMP13MMP2
SCHEMBL2492359 0.79 CBX7 (0.48) KDM4ELMNAGAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030499-B2 1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2011-10-04 US disclosed
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle AVPR1B, AVPR1A, AVPR2 KDM4E 1528/4885LMNA 3349/4885ADAM17 412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.